Search results
Results from the WOW.Com Content Network
Ocular myasthenia gravis (MG) is a disease of the neuromuscular junction resulting in hallmark variability in muscle weakness and fatigability. MG is an autoimmune disease where anomalous antibodies are produced against the naturally occurring acetylcholine receptors in voluntary muscles.
Eye strain, also known as asthenopia (from astheno- 'loss of strength' and -opia 'relating to the eyes'), is a common eye condition that manifests through non-specific symptoms such as fatigue, pain in or around the eyes, blurred vision, headache, and occasional double vision. [1]
The muscle weakness that worsens with activity (abnormal muscle fatigue) in myasthenia gravis [66] is a symptom shared by other neuromuscular diseases. Most of the metabolic myopathies, such as McArdle disease (GSD-V), have abnormal muscle fatigue rather than fixed muscle weakness.
The main symptom of benign fasciculation syndrome is focal or widespread involuntary muscle activity (fasciculation). [1] The benign twitches usually have a constant location. [2] Other common symptoms are generalized fatigue or weakness, paraesthesia or numbness, and muscle cramping or spasms. [1]
Since spasm of accommodation is a result of contraction of the ciliary muscle, the goal would be to relax the ciliary muscle. New studies conducted on rats using perilla frutescens aqueous extract have shown to relax the ciliary muscle. Since there are no known drugs to treat this eye condition, perilla frutescens in an aqueous extract form may ...
Strabismus is an eye disorder in which the eyes do not properly align with each other when looking at an object. [2] The eye that is pointed at an object can alternate. [3] The condition may be present occasionally or constantly. [3] If present during a large part of childhood, it may result in amblyopia, or lazy eyes, and loss of depth ...
Blepharospasm is aggravated by fatigue, stress, and environmental factors such as wind or air pollution. [ 21 ] Although blepharospasm is defined as a bilaterally symmetric disorder that affects both eyes, some research has reported unilateral onset.
There is currently no defined treatment to ameliorate the muscle weakness of CPEO. Treatments used to treat other pathologies causing ophthalmoplegia has not been shown to be effective. [citation needed] Experimental treatment with tetracycline has been used to improve ocular motility in one patient. [11] Coenzyme Q 10 has also been used to ...